{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:18:00Z","timestamp":1791346680065,"version":"4.3.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"publisher","award":["18-80-44-MITC"],"award-info":[{"award-number":["18-80-44-MITC"]}],"id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA016520"],"award-info":[{"award-number":["P30 CA016520"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL007954"],"award-info":[{"award-number":["T32 HL007954"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP2 TR002776"],"award-info":[{"award-number":["DP2 TR002776"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007887","name":"Harvard School of Engineering and Applied Sciences","doi-asserted-by":"publisher","award":["P30 CA016520"],"award-info":[{"award-number":["P30 CA016520"]}],"id":[{"id":"10.13039\/100007887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["129784-IRG-16-188-38-IRG"],"award-info":[{"award-number":["129784-IRG-16-188-38-IRG"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000007","name":"Canadian Aeronautics and Space Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017006","name":"Abramson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jconrel.2019.10.028","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T23:51:50Z","timestamp":1572652310000},"page":"404-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":221,"special_numbering":"C","title":["Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening"],"prefix":"10.1016","volume":"316","author":[{"given":"Pedro P.G.","family":"Guimaraes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4467-5942","authenticated-orcid":false,"given":"Roman","family":"Spektor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchee","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4499-9066","authenticated-orcid":false,"given":"Margaret M.","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakan","family":"El-Mayta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-2244","authenticated-orcid":false,"given":"Michael J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2019.10.028_bib0005","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy","volume":"17","author":"Oberli","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2019.10.028_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805308","article-title":"Dendrimer\u2010based lipid nanoparticles deliver therapeutic FAH mRNA to normalize liver function and extend survival in a mouse model of hepatorenal tyrosinemia type I","author":"Cheng","year":"2018","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2019.10.028_bib0015","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1039\/C6NR08496F","article-title":"Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents","volume":"9","author":"Luo","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2019.10.028_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2018.10.008","article-title":"Biomaterials for vaccine-based cancer immunotherapy","author":"Zhang","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.10.028_bib0025","first-page":"1","article-title":"Delivery technologies for cancer immunotherapy","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.jconrel.2019.10.028_bib0030","doi-asserted-by":"crossref","first-page":"17056","DOI":"10.1038\/natrevmats.2017.56","article-title":"Tools for translation: non-viral materials for therapeutic mRNA delivery","volume":"2","author":"Hajj","year":"2017","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2019.10.028_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2019.04.040","article-title":"Nanoparticles for nucleic acid delivery: applications in Cancer immunotherapy","author":"Mukalel","year":"2019","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.jconrel.2019.10.028_bib0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2019.10.028_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"issue":"18","key":"10.1016\/j.jconrel.2019.10.028_bib0050","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1093\/nar\/29.18.3882","article-title":"Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells","volume":"29","author":"Bettinger","year":"2001","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.jconrel.2019.10.028_bib0055","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2014developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.jconrel.2019.10.028_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1166\/jbns.2018.1498","article-title":"Synthetic vaccine characterization and design","volume":"12","author":"Zhang","year":"2018","journal-title":"J. Bionanosci."},{"issue":"12","key":"10.1016\/j.jconrel.2019.10.028_bib0065","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1039\/C5BM00198F","article-title":"Biomaterials for mRNA delivery","volume":"3","author":"Islam","year":"2015","journal-title":"Biomater. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2019.10.028_bib0070","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/mt.2015.138","article-title":"mRNA: fulfilling the promise of gene therapy","volume":"23","author":"Weissman","year":"2015","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2019.10.028_bib0075","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/CJI.0b013e31815ce501","article-title":"Results of the first phase I\/II clinical vaccination trial with direct injection of mRNA","volume":"31","author":"Weide","year":"2008","journal-title":"J. Immunother."},{"issue":"5","key":"10.1016\/j.jconrel.2019.10.028_bib0080","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/CJI.0b013e3181a00068","article-title":"Direct injection of protamine-protected mRNA: results of a phase 1\/2 vaccination trial in metastatic melanoma patients","volume":"32","author":"Weide","year":"2009","journal-title":"J. Immunother."},{"issue":"7607","key":"10.1016\/j.jconrel.2019.10.028_bib0085","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2019.10.028_bib0090","doi-asserted-by":"crossref","first-page":"41507","DOI":"10.1038\/srep41507","article-title":"Nano-biomimetic carriers are implicated in mechanistic evaluation of intracellular gene delivery","volume":"7","author":"Alipour","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jconrel.2019.10.028_bib0095","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ijc.31577","article-title":"In vivo tumor gene delivery using novel peptideticles: pH\u2010responsive and ligand targeted core\u2013shell nanoassembly","volume":"143","author":"Alipour","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2019.10.028_bib0100","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1038\/ncomms5277","article-title":"Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity","volume":"5","author":"Whitehead","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2019.10.028_bib0105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev-pharmtox-010818-021050","article-title":"Therapeutic oligonucleotides: state of the art","volume":"59","author":"Smith","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"33","key":"10.1016\/j.jconrel.2019.10.028_bib0110","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606944","article-title":"Synthesis and biological evaluation of ionizable lipid materials for the in vivo delivery of messenger RNA to B lymphocytes","volume":"29","author":"Fenton","year":"2017","journal-title":"Adv. Mater."},{"issue":"15","key":"10.1016\/j.jconrel.2019.10.028_bib0115","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1002\/adma.201505822","article-title":"Bioinspired alkenyl amino alcohol ionizable lipid materials for highly potent in vivo mRNA delivery","volume":"28","author":"Fenton","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2019.10.028_bib0120","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201805097","article-title":"Branched\u2010tail lipid nanoparticles potently deliver mRNA in vivo due to enhanced ionization at endosomal pH","author":"Hajj","year":"2019","journal-title":"Small"},{"issue":"8","key":"10.1016\/j.jconrel.2019.10.028_bib0125","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nnano.2014.84","article-title":"In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight","volume":"9","author":"Dahlman","year":"2014","journal-title":"Nat. Nanotechnol."},{"issue":"11","key":"10.1016\/j.jconrel.2019.10.028_bib0130","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1073\/pnas.1322937111","article-title":"Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates","volume":"111","author":"Dong","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2019.10.028_bib0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nbt1402","article-title":"A combinatorial library of lipid-like materials for delivery of RNAi therapeutics","volume":"26","author":"Akinc","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"52","key":"10.1016\/j.jconrel.2019.10.028_bib0140","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805308","article-title":"Dendrimer\u2010based lipid nanoparticles deliver therapeutic FAH mRNA to normalize liver function and extend survival in a mouse model of hepatorenal tyrosinemia type I","volume":"30","author":"Cheng","year":"2018","journal-title":"Adv. Mater."},{"issue":"32","key":"10.1016\/j.jconrel.2019.10.028_bib0145","doi-asserted-by":"crossref","first-page":"12996","DOI":"10.1073\/pnas.1106379108","article-title":"Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery","volume":"108","author":"Siegwart","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2019.10.028_bib0150","series-title":"Delivering the right message: Challenges and Opportunities in Lipid Nanoparticles-mediated Modified mRNA Therapeutics\u2014An Innate Immune System Standpoint, Seminars in Immunology","first-page":"68","author":"Granot","year":"2017"},{"key":"10.1016\/j.jconrel.2019.10.028_bib0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2019.10.028_bib0160","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"5","key":"10.1016\/j.jconrel.2019.10.028_bib0165","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"issue":"7","key":"10.1016\/j.jconrel.2019.10.028_bib0170","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2019.10.028_bib0175","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41598-018-20632-6","article-title":"Oral delivery of siRNA lipid nanoparticles: fate in the GI tract","volume":"8","author":"Ball","year":"2018","journal-title":"Sci. Rep."},{"issue":"39","key":"10.1016\/j.jconrel.2019.10.028_bib0180","doi-asserted-by":"crossref","first-page":"E5702","DOI":"10.1073\/pnas.1606886113","article-title":"Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cells","volume":"113","author":"Yan","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2019.10.028_bib0185","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/acs.nanolett.8b00432","article-title":"A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation","volume":"18","author":"Paunovska","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2019.10.028_bib0190","doi-asserted-by":"crossref","first-page":"14069","DOI":"10.1038\/ncomms14069","article-title":"High-throughput quantitation of inorganic nanoparticle biodistribution at the single-cell level using mass cytometry","volume":"8","author":"Yang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2019.10.028_bib0195","doi-asserted-by":"crossref","first-page":"13325","DOI":"10.1038\/ncomms13325","article-title":"Theranostic barcoded nanoparticles for personalized cancer medicine","volume":"7","author":"Yaari","year":"2016","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.jconrel.2019.10.028_bib0200","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1073\/pnas.1620874114","article-title":"Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics","volume":"114","author":"Dahlman","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2019.10.028_bib0205","series-title":"DNA Tags Help the Hunt for Drugs","author":"Mullard","year":"2016"},{"issue":"42","key":"10.1016\/j.jconrel.2019.10.028_bib0210","doi-asserted-by":"crossref","first-page":"E9944","DOI":"10.1073\/pnas.1811276115","article-title":"High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing","volume":"115","author":"Sago","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2019.10.028_bib0215","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1021\/acs.jpcb.7b10795","article-title":"Structure of lipid nanoparticles containing siRNA or mRNA by dynamic nuclear polarization-enhanced NMR spectroscopy","volume":"122","author":"Viger-Gravel","year":"2018","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.jconrel.2019.10.028_bib0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymeth.2012.02.005","article-title":"Reporter assays for studying quadruplex nucleic acids","volume":"57","author":"Halder","year":"2012","journal-title":"Methods"},{"issue":"26","key":"10.1016\/j.jconrel.2019.10.028_bib0225","doi-asserted-by":"crossref","first-page":"E5859","DOI":"10.1073\/pnas.1805358115","article-title":"Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters","volume":"115","author":"McKinlay","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2019.10.028_bib0230","series-title":"RNA Nanostructures","first-page":"207","article-title":"Preparation and optimization of lipid-like nanoparticles for mRNA delivery","author":"Li","year":"2017"},{"key":"10.1016\/j.jconrel.2019.10.028_bib0235","doi-asserted-by":"crossref","first-page":"22137","DOI":"10.1038\/srep22137","article-title":"Effects of local structural transformation of lipid-like compounds on delivery of messenger RNA","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.jconrel.2019.10.028_bib0240","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/anie.201610209","article-title":"Non\u2010viral CRISPR\/Cas gene editing in vitro and in vivo enabled by synthetic nanoparticle co\u2010delivery of Cas9 mRNA and sgRNA","volume":"56","author":"Miller","year":"2017","journal-title":"Angew. Chemie Int. Ed."},{"issue":"11","key":"10.1016\/j.jconrel.2019.10.028_bib0245","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2019.10.028_bib0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.jconrel.2019.10.028_bib0255","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.jconrel.2019.10.028_bib0260","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nbt.1733","article-title":"Expression of therapeutic proteins after delivery of chemically modified mRNA in mice","volume":"29","author":"Kormann","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.jconrel.2019.10.028_bib0265","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"issue":"16","key":"10.1016\/j.jconrel.2019.10.028_bib0270","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1021\/ja301621z","article-title":"Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation","volume":"134","author":"Chen","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.jconrel.2019.10.028_bib0275","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201805097","article-title":"Branched\u2010tail lipid nanoparticles potently deliver mRNA in vivo due to enhanced ionization at endosomal pH","volume":"15","author":"Hajj","year":"2019","journal-title":"Small"},{"issue":"10","key":"10.1016\/j.jconrel.2019.10.028_bib0280","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/gt.2016.46","article-title":"Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system","volume":"23","author":"DeRosa","year":"2016","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.jconrel.2019.10.028_bib0285","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/ki.1996.487","article-title":"A randomized controlled study of iron supplementation in patients treated with erythropoietin","volume":"50","author":"Macdougall","year":"1996","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.jconrel.2019.10.028_bib0290","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/cc2897","article-title":"Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?","volume":"8","author":"Coleman","year":"2004","journal-title":"Crit. Care"},{"key":"10.1016\/j.jconrel.2019.10.028_bib0295","doi-asserted-by":"crossref","DOI":"10.1021\/acs.nanolett.8b01101","article-title":"Lipid nanoparticle formulations for enhanced co-delivery of siRNA and mRNA","author":"Ball","year":"2018","journal-title":"Nano Lett."},{"issue":"4","key":"10.1016\/j.jconrel.2019.10.028_bib0300","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.nano.2016.12.014","article-title":"Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA","volume":"13","author":"Kulkarni","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2019.10.028_bib0305","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","article-title":"On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA","volume":"12","author":"Kulkarni","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2019.10.028_bib0310","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1620874114","article-title":"Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics","author":"Dahlman","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2019.10.028_bib0315","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0006-3495(95)80369-3","article-title":"Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly (ethylene glycol)","volume":"68","author":"Kenworthy","year":"1995","journal-title":"Biophys. J."},{"issue":"49","key":"10.1016\/j.jconrel.2019.10.028_bib0320","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.1021\/jacs.8b08976","article-title":"Nanoparticles that deliver RNA to bone marrow identified by in vivo directed evolution","volume":"140","author":"Sago","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2019.10.028_bib0325","article-title":"Nanoparticles containing oxidized cholesterol deliver mRNA to the liver microenvironment at clinically relevant doses","author":"Paunovska","year":"2019","journal-title":"Adv. Mater."},{"issue":"15","key":"10.1016\/j.jconrel.2019.10.028_bib0330","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1093\/nar\/19.15.4293","article-title":"Simplified mammalian DNA isolation procedure","volume":"19","author":"Laird","year":"1991","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.jconrel.2019.10.028_bib0335","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1073\/pnas.0910603106","article-title":"Lipid-like materials for low-dose, in vivo gene silencing","volume":"107","author":"Love","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2019.10.028_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2019.07.018","article-title":"Endocytic profiling of Cancer cell models reveals critical factors influencing lipid nanoparticle mediated mRNA delivery and protein expression","author":"Sayers","year":"2019","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2019.10.028_bib0345","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12951-018-0401-y","article-title":"Kinetics of mRNA delivery and protein translation in dendritic cells using lipid-coated PLGA nanoparticles","volume":"16","author":"Yasar","year":"2018","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2019.10.028_bib0350","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood.V98.1.49","article-title":"Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells","volume":"98","author":"Van Tendeloo","year":"2001","journal-title":"Blood"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919305929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919305929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:07:11Z","timestamp":1778674031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919305929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":70,"alternative-id":["S0168365919305929"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.10.028","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}